BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7539741)

  • 1. Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters.
    Giri SN; Sharma AK; Hyde DM; Wild JS
    Exp Lung Res; 1995; 21(2):287-307. PubMed ID: 7539741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.
    Giri SN; Hyde DM; Braun RK; Gaarde W; Harper JR; Pierschbacher MD
    Biochem Pharmacol; 1997 Dec; 54(11):1205-16. PubMed ID: 9416971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.
    Giri SN; Hyde DM
    Am J Pathol; 1988 Dec; 133(3):525-36. PubMed ID: 2462354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of niacin on bleomycin-induced increases in myeloperoxidase, prolyl hydroxylase, and superoxide dismutase activities and collagen accumulation in the lungs of hamsters.
    O'Neill CA; Giri SN
    J Biochem Toxicol; 1992; 7(4):229-39. PubMed ID: 1284083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of delayed treatment with transforming growth factor-beta soluble receptor in a three-dose bleomycin model of lung fibrosis in hamsters.
    Wang Q; Hyde DM; Gotwals PJ; Giri SN
    Exp Lung Res; 2002 Sep; 28(6):405-17. PubMed ID: 12217209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
    Iyer SN; Margolin SB; Hyde DM; Giri SN
    Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
    Iyer SN; Wild JS; Schiedt MJ; Hyde DM; Margolin SB; Giri SN
    J Lab Clin Med; 1995 Jun; 125(6):779-85. PubMed ID: 7539478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice.
    Giri SN; Biring I; Nguyen T; Wang Q; Hyde DM
    Nitric Oxide; 2002 Sep; 7(2):109-18. PubMed ID: 12223180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters.
    Giri SN; Misra HP; Chandler DB; Chen ZL
    Exp Mol Pathol; 1983 Dec; 39(3):317-26. PubMed ID: 6196228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
    Iyer SN; Gurujeyalakshmi G; Giri SN
    J Pharmacol Exp Ther; 1999 Apr; 289(1):211-8. PubMed ID: 10087006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dibutyrylcyclic adenosine monophosphate on bleomycin-induced lung toxicity in hamsters.
    O'Neill CA; Giri SN; Wang Q; Perricone MA; Hyde DM
    J Appl Toxicol; 1992 Apr; 12(2):97-111. PubMed ID: 1372923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters.
    Ben Yehuda A; Lossos IS; Or R; Ben Chetrit E; Goldstein RH; Conner MW; Breuer R
    Pulm Pharmacol Ther; 1997; 10(1):61-5. PubMed ID: 9344834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose and regimen effects of poly ICLC, an interferon inducer, in a multi-dose bleomycin model of interstitial pulmonary fibrosis.
    Wild JS; Hyde DM; Giri SN
    Pharmacol Toxicol; 1994 Jul; 75(1):42-8. PubMed ID: 7526360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of an interferon inducer bropirimine on bleomycin-induced lung fibrosis in hamsters.
    Zia S; Hyde DM; Giri SN
    Pharmacol Toxicol; 1992 Jul; 71(1):11-8. PubMed ID: 1381833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposome encapsulation improves the effect of antifibrotic agent in rat lung fibrosis.
    Poiani GJ; Greco M; Choe JK; Fox JD; Riley DJ
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1623-7. PubMed ID: 7524983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of bleomycin-induced pulmonary injury by cyclosporin A.
    Lossos IS; Or R; Goldstein RH; Conner MW; Breuer R
    Exp Lung Res; 1996; 22(3):337-49. PubMed ID: 8792125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
    Chen J; Ziboh V; Giri SN
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a bleomycin hamster model of subchronic lung fibrosis.
    Zia S; Hyde DM; Giri SN
    Pathology; 1992 Jul; 24(3):155-63. PubMed ID: 1279506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment in coupled beta-adrenergic receptor and adenylate cyclase system during bleomycin-induced lung fibrosis in hamsters.
    Giri SN; Sanford DA; Robison TW; Tyler NK
    Exp Lung Res; 1987; 13(4):401-16. PubMed ID: 2452079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: the role of NAD and ATP.
    O'Neill CA; Giri SN
    Exp Lung Res; 1994; 20(1):41-56. PubMed ID: 7514122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.